11 results · 27ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

TRIGEN RETROGRADE FEMORAL, SUPRACONDYLAR AND TIBIAL NAILS

FDA 510(k)
FDA Class 2 ·Orthopedic

ACUMATCH GXL 15DEG LINER 36MM SZ J

FDA Adverse Event
Injury ·EXACTECH, INC.·Product code JDI·April 19, 2024

LAXTEX POWDERED EXAMINATION GLOVE WITH PROTEIN LABELING CLAIM (100 MICROGRAMS OR LESS)

FDA 510(k)
FDA Class 1 ·General Hospital

PTA, PTV, ATRIOSEPTOSTOMY, ANGIOGRAPHIC, SIZING CATHETERS

FDA 510(k)
FDA Class 2 ·Cardiovascular

BD SAF-T-INTIMA¿ CLOSED IV CATHETER SYSTEM

FDA Adverse Event
Malfunction ·BECTON DICKINSON MEDICAL DEVICES CO., LTD. SUZHOU·Product code FOZ·April 8, 2022

CARELINK SYSTEM

FDA Adverse Event
Injury ·RICE CREEK MFG·Product code LWS·April 10, 2013

DUAL CUT SAGITTAL BLADE

FDA Adverse Event
Malfunction ·STRYKER INSTRUMENTS·Product code DWH·April 29, 2008

PROXIMATE ILS CURVED CIR STAPL

FDA Adverse Event
Injury ·ETHICON ENDO-SURGERY, LLC.·Product code GDW·April 12, 2011

The PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all communication functions for the pulse generator.

FDA Enforcement
Class II ·Ongoing·Boston Scientific Corporation·September 7, 2022

The Programmer/Recorder/Monitor (PRM) is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all communication functions for the pulse generator.

FDA Enforcement
Class II ·Ongoing·Boston Scientific Corporation·September 7, 2022

The PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all communication functions for the pulse generator.

FDA Enforcement
Class II ·Ongoing·Boston Scientific Corporation·September 7, 2022